ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

NCI’s Breast Cancer Screening Guidelines Released In Draft

September 24, 1993

Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding

June 29, 1979

Racial Differences In Survival Increase According To Stage

August 31, 2007

Enck New ACCC President, King President Elect

March 20, 1987